0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Anticancer Drug Development Guide - Preclinical Screening, Clinical Trials, and Approval (Paperback, Softcover reprint of the original 1st ed. 2004) Loot Price: R4,527
Discovery Miles 45 270
Anticancer Drug Development Guide - Preclinical Screening, Clinical Trials, and Approval (Paperback, Softcover reprint of the...

Anticancer Drug Development Guide - Preclinical Screening, Clinical Trials, and Approval (Paperback, Softcover reprint of the original 1st ed. 2004)

Beverly A. Teicher, Paul A. Andrews

Series: Cancer Drug Discovery and Development

 (sign in to rate)
Loot Price R4,527 Discovery Miles 45 270 | Repayment Terms: R424 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent. " The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these "anticancer" molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of "antileukemia" agents, but that other tumor models would be needed to discover drugs active against solid tumors.

General

Imprint: HumanaPress
Country of origin: United States
Series: Cancer Drug Discovery and Development
Release date: August 2012
First published: 2004
Editors: Beverly A. Teicher • Paul A. Andrews
Dimensions: 254 x 178 x 24mm (L x W x T)
Format: Paperback
Pages: 451
Edition: Softcover reprint of the original 1st ed. 2004
ISBN-13: 978-1-4684-9841-7
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 1-4684-9841-X
Barcode: 9781468498417

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners